Loading...
XNAS
PDEX
Market cap131mUSD
Dec 05, Last price  
40.22USD
1D
-1.18%
1Q
5.32%
Jan 2017
755.74%
Name

Pro-Dex Inc

Chart & Performance

D1W1MN
XNAS:PDEX chart
P/E
14.61
P/S
1.97
EPS
2.75
Div Yield, %
—
Shrs. gr., 5y
-3.79%
Rev. gr., 5y
13.84%
Revenues
67m
+23.68%
17,061,00021,563,00025,126,00021,122,00023,211,00027,109,00017,257,00012,249,00010,812,00013,383,00020,158,00021,943,00022,465,00027,172,00034,834,00038,029,00042,041,00046,087,00053,844,00066,593,000
Net income
9m
+322.10%
827,000506,000317,000-2,845,000-2,968,0002,640,000-876,000-1,784,000-488,000-365,000822,0005,084,0001,621,0004,148,0006,112,0004,450,0004,572,0007,074,0002,127,0008,978,000
CFO
-2m
L
55,0001,480,0002,018,0001,718,0003,240,0002,898,00045,000-1,271,000-329,000-775,000466,0003,235,0003,096,0003,326,0005,897,000-2,078,000-847,0005,462,0006,199,000-1,682,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
URL
https://www.pro-dex.com/
IPO date
May 31, 1994
Employees
134
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT